We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.82B
AUM Growth
-$26.9M
Cap. Flow
-$65.9M
Cap. Flow %
-3.62%
Top 10 Hldgs %
25.49%
Holding
265
New
15
Increased
38
Reduced
176
Closed
16

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$20.4M
2
LKQ icon
LKQ Corp
LKQ
+$13.6M
3
PRLB icon
Protolabs
PRLB
+$5.49M
4
GNTX icon
Gentex
GNTX
+$5.07M
5
PRMB
Primo Brands
PRMB
+$4.23M

Top Sells

Rank Stock Value
1
LRN icon
Stride
LRN
+$15.4M
2
YOU icon
Clear Secure
YOU
+$9.41M
3
SITM icon
SiTime
SITM
+$7.56M
4
MGPI icon
MGP Ingredients
MGPI
+$6.55M
5
DOCS icon
Doximity
DOCS
+$6.52M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Technology 27.79%
3 Industrials 15.85%
4 Communication Services 7.19%
5 Consumer Discretionary 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDWR icon
26
Radware
RDWR
$1.19B
$19.9M 1.09%
882,134
-49,517
-5% -$1.13M
WIX icon
27
WIX.com
WIX
$2.52B
$19.3M 1.06%
89,778
-4,507
-5% -$861K
SUPN icon
28
Supernus Pharmaceuticals
SUPN
$2.77B
$19.1M 1.05%
528,345
-12,443
-2% -$438K
SSTK icon
29
Shutterstock
SSTK
$219M
$16.6M 0.91%
547,520
+18,133
+3% +$570K
LKQ icon
30
LKQ Corp
LKQ
$6.29B
$16.3M 0.89%
443,030
+355,815
+408% +$13.6M
CRAI icon
31
CRA International
CRAI
$1.06B
$15.8M 0.87%
84,647
-1,823
-2% -$347K
ITRN icon
32
Ituran Location and Control
ITRN
$1.05B
$15.8M 0.87%
507,552
-9,147
-2% -$260K
BCRX icon
33
BioCryst Pharmaceuticals
BCRX
$2.4B
$15.7M 0.86%
2,081,316
-82,427
-4% -$626K
NBIX icon
34
Neurocrine Biosciences
NBIX
$16.6B
$15.1M 0.83%
110,632
-6,785
-6% -$839K
RBA icon
35
RB Global
RBA
$17.5B
$14.9M 0.82%
165,652
-8,392
-5% -$751K
NGVT icon
36
Ingevity
NGVT
$2.68B
$14.5M 0.8%
356,269
-23,402
-6% -$974K
CEVA icon
37
CEVA Inc
CEVA
$1.08B
$14.1M 0.78%
447,361
-5,180
-1% -$144K
GNTX icon
38
Gentex
GNTX
$5.07B
$13.1M 0.72%
454,883
+169,586
+59% +$5.07M
FOLD
39
DELISTED
Amicus Therapeutics
FOLD
$12.9M 0.71%
1,371,080
+398,942
+41% +$4.15M
DOX icon
40
Amdocs
DOX
$6.22B
$12.9M 0.71%
151,658
-15,365
-9% -$1.35M
MMS icon
41
Maximus
MMS
$3.1B
$12.9M 0.71%
172,546
-1,233
-0.7% -$101K
OZK icon
42
Bank OZK
OZK
$5.61B
$12.8M 0.7%
287,016
-22,335
-7% -$1.02M
KNSA icon
43
Kiniksa Pharmaceuticals
KNSA
$5.93B
$12.7M 0.7%
642,752
-6,878
-1% -$157K
ACAD icon
44
Acadia Pharmaceuticals
ACAD
$5.03B
$12.5M 0.69%
681,537
-35,609
-5% -$575K
ALKS icon
45
Alkermes
ALKS
$8.25B
$12.4M 0.68%
429,927
-21,730
-5% -$625K
IOVA icon
46
Iovance Biotherapeutics
IOVA
$2.87B
$11.8M 0.65%
1,594,532
-84,625
-5% -$784K
POOL icon
47
Pool Corp
POOL
$7.5B
$11.6M 0.64%
33,967
-2,930
-8% -$1.07M
MTN icon
48
Vail Resorts
MTN
$5.3B
$11.1M 0.61%
59,215
-3,096
-5% -$554K
LQDT icon
49
Liquidity Services
LQDT
$1.32B
$10.8M 0.59%
334,255
-33,047
-9% -$838K
AEHR icon
50
Aehr Test Systems
AEHR
$3.36B
$10.5M 0.58%
634,391
+235,625
+59% +$3.14M
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Rice Hall James & Associates held 265 positions worth $1.82B, down 1.5% from $1.85B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.9M in Q4 2024, closing 16 positions and reducing 176 holdings. Its most notable exit was SiTime, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Protolabs worth $5.97M.

  • Rice Hall James & Associates's largest Q4 2024 buy was Protolabs: 152,783 shares worth $5.97M.
  • Rice Hall James & Associates added most to Shift4 in Q4 2024, an estimated $20.4M increase.
  • Rice Hall James & Associates's biggest Q4 2024 reduction was Stride, cutting an estimated $15.4M.
  • Rice Hall James & Associates fully exited SiTime in Q4 2024, selling an estimated $7.56M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.82B portfolio in Q4 2024.
  • Rice Hall James & Associates opened 15 new positions and closed 16 in Q4 2024.
  • Rice Hall James & Associates's portfolio value fell 1.5% quarter-over-quarter to $1.82B.

Based on Rice Hall James & Associates's 13F filing for Q4 2024, filed 31 Jan 2025.